yttrium has been researched along with deoxycytidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, AB; Gates, VL; Habib, A; Hickey, R; Kircher, S; Lewandowski, RJ; Mulcahy, MF; Newman, S; Nimeiri, H; Salem, R; Vouche, M | 1 |
| Hickey, R; Mulcahy, M; Salem, R | 1 |
| Putnam, SG | 1 |
1 trial(s) available for yttrium and deoxycytidine
| Article | Year |
|---|---|
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiation-Sensitizing Agents; Radiometry; Time Factors; Treatment Outcome; Yttrium | 2014 |
2 other study(ies) available for yttrium and deoxycytidine
| Article | Year |
|---|---|
In reply to Putnam.
Topics: Chemoradiotherapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Radiation-Sensitizing Agents; Yttrium | 2014 |
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of Yttrium-90 radioembolization: in regard to Hickey et al.
Topics: Chemoradiotherapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Radiation-Sensitizing Agents; Yttrium | 2014 |